BioDelivery Sciences International Inc. (BDSI) Profile

Profile for BioDelivery Sciences International Inc. (BDSI)


Business Description: BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Address:	801 Corporate Center Drive, Suite 210, Raleigh, NC, 27607
Telephone:	(919) 582-9050	Website:	www.bdsi.com
Facsimile:	(919) 582-9051	Email:	N/A


Details

CEO:	Dr. Mark A. Sirgo,Pharm.D.
Employees:	20	Market Cap:	60.6 m
Issue Type:	CS
Auditor:	Cherry, Bekaert & Holland, L.L.P.
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0001103021
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for BioDelivery Sciences International Inc.

Research stocks or mutual funds related to BioDelivery Sciences International Inc. by keywords or tags. Find companies that have a similar focus to BDSI. The keywords below have been associated to BDSI by either user submission or electronic means.

pain control biotech research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment european business development pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing pharma manufacturing pharma license pharmaceutical supply chain novartis pharmaceuticals active pharmaceutical ingredient pharmaceutical cro active pharmaceutical ingredients pharmaceutical sales pharmaceutical distributors pharma in licensing pharmaceutical development pharmaceutical reports pharmaceutical consultant Drugs pharmaceutical auctions pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation pharmaceutical article contract pharmaceutical pharmaceutical consulting biopharmaceuticals pharmaceutical events pharmaceutical industry pharmaceutical sale pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical specialty pharmaceutical out licensing pharmaceutical business development Healthcare pharmaceutical preparation pharmaceutical sector bio pharmaceuticals pharmaceutical innovation sandoz pharmaceuticals pharmaceutical

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.